» Articles » PMID: 3261424

Meta-iodobenzylguanidine (mIBG) Scans in Neuroblastoma: Sensitivity and Specificity, a Review of 115 Scans

Overview
Date 1988 Jan 1
PMID 3261424
Citations 19
Authors
Affiliations
Soon will be listed here.
Citing Articles

Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.

Streby K, Parisi M, Shulkin B, LaBarre B, Bagatell R, Diller L Pediatr Blood Cancer. 2023; 70(8):e30418.

PMID: 37199022 PMC: 10511015. DOI: 10.1002/pbc.30418.


Advancing therapy for neuroblastoma.

Qiu B, Matthay K Nat Rev Clin Oncol. 2022; 19(8):515-533.

PMID: 35614230 DOI: 10.1038/s41571-022-00643-z.


Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.

Yanik G, Parisi M, Naranjo A, Nadel H, Gelfand M, Park J J Nucl Med. 2017; 59(3):502-508.

PMID: 28887399 PMC: 5868501. DOI: 10.2967/jnumed.117.195883.


123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat G, Adam J, Caron H, Kremer L, Hooft L Cochrane Database Syst Rev. 2015; (9):CD009263.

PMID: 26417712 PMC: 4621955. DOI: 10.1002/14651858.CD009263.pub2.


Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management.

Subedi N, Prestwich R, Chowdhury F, Patel C, Scarsbrook A Cancer Imaging. 2013; 13(3):407-22.

PMID: 24240099 PMC: 3830426. DOI: 10.1102/1470-7330.2013.0034.